Skin News and Research

RSS

Lyme disease - a tough nut to crack!

The bacteria that cause Lyme disease, the most common tick-borne illness in the United States, can linger in mouse tissues long after a full round of antibiotic treatment is completed, report researchers from the University of California, Davis.

2 Apr 2008

New breakthrough discovery on TB

Medical scientists from the University of Leicester, together with colleagues from St Georges, University of London, funded principally by the Medical Research Council (MRC) and The Wellcome Trust, have published details of a new breakthrough discovery on TB.

1 Apr 2008

Community-acquired MRSA spreads

Drug resistant hospital superbugs like MRSA have been kept under control in Denmark for more than 30 years.

1 Apr 2008

Superbugs resistant to everything - Doctors running out of treatments

Doctors are running out of treatments for today's trauma victims and critically ill patients because of infections due to drug resistant microbes even after resorting to using medicines thrown out 20 years ago because of severe side effects, scientists heard at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.

1 Apr 2008

Stem cells from hair follicles may help 'grow' new blood vessels

For a rich source of stem cells to be engineered into new blood vessels or skin tissue, clinicians may one day look no further than the hair on their patients' heads, according to new research published earlier this month by University at Buffalo engineers.

31 Mar 2008

Saving cancer patients' skin

Becky Sasaki has the quick laugh and easy smile of a woman who continues to thrive despite her four-year wrestling match with lung cancer.

31 Mar 2008

Hairdressers at an increased risk for cancers

According to the World Health Organisation (WHO), hair dyes and other chemicals place hairdressers at an increased risk for cancer.

31 Mar 2008

University of Kentucky physician revolutionizes gene research

A dramatic new study published in the most recent issue of Nature questions some of the mechanisms underlying a new class of drugs based on Nobel Prize-winning work designed to fight diseases ranging from macular degeneration to diabetes.

28 Mar 2008

First comprehensive database of microorganisms known to live in the mouth

Scientists know more today than ever before about the microbes that inhabit our mouths.

26 Mar 2008

Therapeutic cloning treats Parkinson's disease in mice

Research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson's disease in mice.

25 Mar 2008

Severe psoriasis linked to serious medical conditions including cardiovascular disease, depression and cancer

It has long been known that psoriasis, a chronic skin condition characterized by thick, red, scaly plaques that itch and bleed, can have a significant negative impact on a patient's overall quality of life.

25 Mar 2008

Cloned stem cells successful in treating Parkinson's disease

Scientists in the U.S. have had success in treating Parkinson's disease in mice by using cloned stem cells.

24 Mar 2008

NanoBio completes interim analysis of phase 2 clinical trial in onychomycosis

NanoBio Corporation has announced that it has seen promising results from an interim analysis of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details remain confidential, the results clearly justify completing the study, according to NanoBio scientists

24 Mar 2008

Skin patch gives bird flu vaccine a big boost

Researchers testing an experimental skin patch designed to boost an H5N1 vaccine say preliminary results have been promising.

21 Mar 2008

New medical adhesive

The U.S. Food and Drug Administration today approved a new medical adhesive (a fibrin sealant) called Artiss for use in attaching skin grafts onto burn patients.

20 Mar 2008

New interventional radiology treatment shows promise for complications from bone marrow, stem cell tranplants

The standard treatment to treat graft-versus-host disease (GVHD) after bone marrow or cord blood transplant is intravenous (IV) steroids that alter the immune response; however, it is not always effective and failure results in very high mortality.

19 Mar 2008

SnowWorld, an interactive, virtual-reality video game helps burn patients with pain relief

To a patient recovering from severe burns, no place would be more soothing than a polar landscape of gently falling snowflakes, snowmen, penguins, igloos and icy rivers.

19 Mar 2008

Compound present naturally in grape skin fights the complications of diabetes

Research carried out by scientists at the Peninsula Medical School in the South West of England has found that resveratrol, a compound present naturally in grape skin, can protect against the cellular damage to blood vessels caused by high production of glucose in diabetes, according to a paper published in the science journal "Diabetes, Obesity and Metabolism" this week.

19 Mar 2008

Most women unaware of uterine fibroid embolization

A study presented at the Society of Interventional Radiology's 33rd Annual Scientific Meeting shows of 105 patients in the Atlanta metro area, only 18 percent of the women who saw a private practice gynecologist were told about uterine fibroid embolization (UFE), a minimally invasive treatment for uterine fibroids provided by interventional radiologists.

19 Mar 2008

FDA sends approvable letter for Ceftobiprole as treatment of complicated skin infections

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), has announced that it received an approvable letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ceftobiprole for the treatment of complicated skin and skin structure infections, including diabetic foot infections.

19 Mar 2008